The Indianapolis-based health insurance company reported earnings of $1.14 per share, below analysts' forecasts for earnings of $1.22 per share.
Revenue rose by 6.6% year-over-year to $20 billion during the quarter, slightly higher than analysts estimates for revenue of $19.9 billion.
The company said medical enrollment rose by 1.1 million members to 38.6 million members during the quarter.
"Our solid fourth quarter results reflected a continuation of our positive operating momentum as we ended the year serving 38.6 million members across our Commercial and Government markets," CEO Joseph Swedish said in a statement. "We believe our strategy will be enhanced with the pending acquisition of Cigna, which we continue to expect should close in the second half of 2016."
Anthem stock closed at $137.76 on Tuesday.
Separately, recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
TheStreet Ratings rates this stock as a "buy" with a ratings score of A-. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow.
You can view the full analysis from the report here: ANTM